Tandem Diabetes Care (NASDAQ: TNDM)
Tandem Diabetes Care Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Tandem Diabetes Care Company Info
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
News & Analysis
Why Tandem Diabetes Care Stock Took It on the Chin Tuesday
Flat revenue growth might be in store for the company in a very crucial market.
Why Tandem Diabetes Care Stock Thrashed the Market Today
At a stroke, it's got a product authorized for a specific use in 27 countries.
Why Tandem Diabetes Stock Just Jumped 22%
Tandem Diabetes stock is showing great growth -- but miserable profits.
1 Beaten-Down Stock That Could Make You Richer
Don't give up on this healthcare stock too soon.
Why Tandem Diabetes Care Stock Was Zooming Higher Today
One product in particular could juice the company's fundamentals, a pundit believes.
Why Tandem Diabetes Care Stock Popped Today
Tandem Diabetes climbed as investors focused on its strong outlook for the coming year.
2 Beaten-Down Stocks That Are Worth Buying
Don't be too quick to ignore these stocks.
2 Stocks Under $25 to Buy and Hold for 10 Years
There's no need to break the bank to get in on the action.
Valuation
Podcast Episodes
Who Had the Better Quarter, Tandem Diabetes or Teladoc?
These two disruptive companies reported crazy-good top-line growth, but only one can be the winner.
The Top Healthcare Stocks of 2018: Can They Continue in 2019?
These healthcare stocks crushed the S&P 500's return last year, but that doesn't guarantee they'll be top performers in 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.